In Vitro Immunological Effects of CXCR3 Inhibitor AMG487 on Dendritic Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In Vitro Immunological Effects of CXCR3 Inhibitor AMG487 on Dendritic Cells

Published:2020-04 Issue:2 Volume:68 Page:
ISSN:0004-069X
Container-title:Archivum Immunologiae et Therapiae Experimentalis
language:en
Short-container-title:Arch. Immunol. Ther. Exp.

Author:

Qin Chenchen,Liu Huihui,Tang Bo,Cao Min,Yu Zhengyu,Liu Beichen,Liu Wei,Dong Yujun,Ren Hanyun

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00005-020-00577-3.pdf

Reference39 articles.

1. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245–252

2. Billottet C, Quemener C, Bikfalvi A (2013) CXCR3, a double-edged sword in tumor progression and angiogenesis. Biochim Biophys Acta 1836:287–295

3. Boks MA, Kager-Groenland JR, Haasjes MS, Zwaginga JJ, van Ham SM et al (2012) IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction–a comparative study of human clinical-applicable DC. Clin Immunol 142:332–342

4. Chen T, Guo J, Yang M, Han C, Zhang M et al (2004) Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression. Blood 103:413–421

5. Chen Y, Yin D, Fan B, Zhu X, Chen Q et al (2019) Chemokine CXCL10/CXCR3 signaling contributes to neuropathic pain in spinal cord and dorsal root ganglia after chronic constriction injury in rats. Neurosci Lett 694:20–28

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting CXCL9/10/11–CXCR3 axis: an important component of tumor-promoting and antitumor immunity;Clinical and Translational Oncology;2023-04-19

2. CXCR3 Inhibition Blocks the NF-κB Signaling Pathway by Elevating Autophagy to Ameliorate Lipopolysaccharide-Induced Intestinal Dysfunction in Mice;Cells;2023-01-01

3. Evolving landscape of PD-L2: bring new light to checkpoint immunotherapy;British Journal of Cancer;2022-12-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3